Mark Daniel

Mark Daniel is a seasoned finance executive with over 25 years of experience in strategic finance, accounting, and operations. They possess a robust background in industries such as biotech, manufacturing, and medical devices, having successfully led financing transactions exceeding $1 billion and operational initiatives that resulted in over $100 million in cost improvements. Currently serving as Chief Financial Officer at Atossa Therapeutics, Inc., Mark also has held senior positions at notable companies, including Bruker Spatial Biology, HaloSource, and T-Mobile USA. Mark earned a Bachelor’s degree in Accounting from Washington State University and has demonstrated strong leadership skills by managing teams totaling over 40 employees across various roles.